Genpact Limited
G · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8 | $6 | $9 | $10 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $1 | $2 | $2 | $2 |
| Enterprise Value | $8 | $7 | $10 | $11 |
| Revenue | $5 | $4 | $4 | $4 |
| % Growth | 6.5% | 2.4% | 8.7% | – |
| Gross Profit | $2 | $2 | $2 | $1 |
| % Margin | 35.5% | 35.1% | 35.1% | 35.6% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 17.9% | 17.3% | 14.9% | 17.6% |
| Net Income | $1 | $1 | $0 | $0 |
| % Margin | 10.8% | 14.1% | 8.1% | 9.2% |
| EPS Diluted | 2.85 | 3.41 | 1.88 | 1.91 |
| % Growth | -16.4% | 81.4% | -1.6% | – |
| Operating Cash Flow | $1 | $0 | $0 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | $1 |